Pharmafile Logo
Pharmafocus logo
Advanced Search

NHS

Showing 15 posts of 1081 posts found.

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024
Medical Communications ATTR-CM, Cardiology, NHS, Pfizer, tafamidis

NHS England has announced that it has accepted Pfizer’s drug, tafamidis, for the treatment of transthyretin amyloidosis cardiomyopathy (ATTR-CM).

News

NICE recommends migraine treatment for NHS use

April 11, 2024
Medical Communications NHS, NICE, Neurology, migraine

The National Institute for Health and Care Excellence (NICE) has shared draft guidance recommending AbbVie’s Aquipta (atogepant) as an option …

News

Novo Nordisk launches Wegovy in the UK

September 4, 2023
Medical Communications NHS, NICE, Novo Nordisk, Obesity, Wegovy, weight loss

Novo Nordisk has today announced that Wegovy (semaglutide injection) is now available in the UK through a controlled and limited …

News

Bristol Myers Squibb’s Sotyktu recommended for NHS use for adult patients with psoriasis

June 28, 2023
Medical Communications Dermatology, NHS, Sotyktu, bristol myers squibb, psoriasis

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has recommended Sotyktu (deucravacitinib) …

News
weight-2036971_960_720

UK plans £40m drug trial for Novo Nordisk’s Wegovy to aid NHS in treating obesity

June 7, 2023
Research and Development NHS, Novo Nordisk, Obesity, Wegovy, clinical trial, obesity

The UK Government has announced plans to launch a pilot programme which will provide GPs with Novo Nordisk’s Wegovy (semaglutide), …

News

Report finds NHS may miss out on new drugs due to rising costs

June 5, 2023
Sales and Marketing LSE, LSHTM, NHS, Pharmacy, University of York, drug prices

Figures from a team at the University of York, the London School of Economics and Political Science (LSE) and the …

News

NICE approves first treatment for obstructive HCM for NHS use

June 2, 2023
Medical Communications Bristol-Myers Squibb, Cardiology, NHS, NICE, obstructive HCM

The National Institute for Health and Care Excellence (NICE) has announced that it has approved mavacamten (Camzyos) for the treatment …

News

NICE recommends Pfizer’s rimegepant for preventing episodic migraine attacks

June 2, 2023
Medical Communications NHS, NICE, Neurology, Pfizer, migraine

The National Institute for Health and Care Excellence (NICE) has announced that it has recommended an oral treatment for the …

News
milad-fakurian-58z17lnvs4u-unsplash_2

NHS given guidance on offering genetic testing to stroke patients

May 19, 2023
Medical Communications NHS, Neurology, blood clot, genetic testing, stroke

The NHS has been given draft guidance on offering gene tests to patients who have had a stroke caused by …

News

NICE recommends Hepcludex for NHS use to treat aggressive form of viral hepatitis

May 15, 2023
Medical Communications NHS, NICE, Virology, hepatitis

The National Institute for Health and Care Excellence (NICE) has recommended Hepcludex (bulevirtide) for the treatment of chronic hepatitis delta …

News
nhs_sign

NHS in Scotland makes rheumatoid arthritis drug available

September 14, 2021
Manufacturing and Production Galapagos UK, NHS, Scotland, filgotinib, rheumatoid arthritis

The Scottish Medicines Consortium (SMC) have recommended the use of Galapagos UK’s JYSELECA® (filgotinib) for eligible patients with severe active …

News
mufid-majnun-oi20ehignd4-unsplash

Long COVID: 15 studies launched with £19.6 million government funding

July 19, 2021
Sales and Marketing NHS, UK, long covid

The UK government has announced the launch of 15 new extensive studies, backed by £19.6 million in funding, to investigate …

News
gilead-sciences

‘It’s Time for Trodelvy’: Charity launches petition against Gilead for drug access

July 19, 2021
Sales and Marketing Cancer, Gilead, NHS, charity

The charity Breast Cancer Now has launched a petition calling on Gilead to provide free-of-charge access to its new treatment …

News

Fears for pregnant women as COVID restrictions ease

July 15, 2021
COVID-19, NHS, Vaccine, maternity

The Royal College of Obstetricians and Gynaecologists (RCOG) and the Royal College of Midwives (RCM) have expressed fears over the …

News
nhs_old_hospital_1

Lethal triple mix of winter viruses could “push NHS to breaking point”

July 15, 2021
COVID-19, NHS, influenza

A report from the Academy of Medical Sciences has found that a lethal triple mix of COVID-19, influenza, and the …

News

Latest content

FDA approves AbbVie’s Skyrizi for UC treatment

June 20, 2024

Takeda shares data from phase 3 trial of CIPD treatment

June 20, 2024

EC grants marketing authorisation to Sobi’s Altuvoct for haemophilia A treatment

June 19, 2024

First patient dosed in Assembly Biosciences’ phase 1b trial for hepatitis B treatment

June 19, 2024

FDA approves Merck’s Capvaxive for prevention of pneumococcal disease

June 18, 2024